KRAS, NRAS and BRAF mutation profiling in a series of 90 metastasic colorectal cancer spanish patients. An estimation of cost savings.
Rodón Natalia1, Román Ruth1, Verdú Montse1,2, Montes Mª del Mar3, García-Peláez Beatriz1, Diaz Olga1, Lacasa Carmen3 and Puig Xavier1,2.
1 BIOPAT. Biopatologia Molecular S.L., Barcelona (Spain). 2 HISTOPAT Laboratoris S.L., Barcelona (Spain). 3 Departamento de Farmacia. Hospital de Barcelona (SCIAS), Grup Assistència, Barcelona (Spain).
Background: Metastasic colorectal cancer (mCRC) patients harbouring a mutation in codon 12 or 13 […]